| Targeting CXCR2 enhances chemotherapeutic response, inhibits mammary tumor growth, angiogenesis, and lung metastasis B Sharma, DM Nawandar, KC Nannuru, ML Varney, RK Singh Molecular cancer therapeutics 12 (5), 799-808, 2013 | 145 | 2013 |
| CXCL8 and its cognate receptors in melanoma progression and metastasis S Singh, AP Singh, B Sharma, LB Owen, RK Singh Future Oncology 6 (1), 111-116, 2010 | 137 | 2010 |
| Role of chemokine receptor CXCR2 expression in mammary tumor growth, angiogenesis and metastasis KC Nannuru, B Sharma, ML Varney, RK Singh Journal of carcinogenesis 10, 2011 | 79 | 2011 |
| Targeting CXCR1/CXCR2 receptor antagonism in malignant melanoma B Sharma, S Singh, ML Varney, RK Singh Expert opinion on therapeutic targets 14 (4), 435-442, 2010 | 75 | 2010 |
| Interleukin17–CXCR2 axis facilitates breast cancer progression by up-regulating neutrophil recruitment RKS Lingyun Wu, Mohammad Awaji, Sugandha Saxena, Michelle L Varney, Bhawna ... The American Journal of Pathology, 2019 | 56* | 2019 |
| αB-crystallin: Portrait of a malignant chaperone as a cancer therapeutic target D Malin, V Petrovic, E Strekalova, B Sharma, VL Cryns Pharmacology & therapeutics 160, 1-10, 2016 | 48 | 2016 |
| Induction of CXCR2 ligands, stem cell-like phenotype, and metastasis in chemotherapy-resistant breast cancer cells RKS Bhawna Sharma, Michelle L. Varney, Sugandha Saxena, Lingyun Wu Cancer Letters, 2016 | 46 | 2016 |
| Host Cxcr2-dependent regulation of mammary tumor growth and metastasis B Sharma, KC Nannuru, ML Varney, RK Singh Clinical & experimental metastasis 32, 65-72, 2015 | 44 | 2015 |
| Assessing NLRP3 inflammasome activation by nanoparticles B Sharma, CB McLeland, TM Potter, ST Stern, PP Adiseshaiah Characterization of Nanoparticles Intended for Drug Delivery, 135-147, 2018 | 37 | 2018 |
| ERK-regulated αB-crystallin induction by matrix detachment inhibits anoikis and promotes lung metastasis in vivo D Malin, E Strekalova, V Petrovic, H Rajanala, B Sharma, A Ugolkov, ... Oncogene 34 (45), 5626-5634, 2015 | 36 | 2015 |
| The efficacy of nuclease-resistant Chol-siRNA in primary breast tumors following complexation with PLL-PEG (5K) VV Ambardekar, RR Wakaskar, B Sharma, J Bowman, W Vayaboury, ... Biomaterials 34 (20), 4839-4848, 2013 | 35 | 2013 |
| CXCR2: a novel mediator of mammary tumor bone metastasis B Sharma, KC Nannuru, S Saxena, ML Varney, RK Singh International journal of molecular sciences 20 (5), 1237, 2019 | 20 | 2019 |
| Emerging candidates in breast cancer stem cell maintenance, therapy resistance and relapse B Sharma, RK Singh Journal of carcinogenesis 10, 2011 | 17 | 2011 |
| Nanotechnology as a delivery tool for precision cancer therapies B Sharma, RM Crist, PP Adiseshaiah The AAPS Journal 19, 1632-1642, 2017 | 13 | 2017 |
| Immunogenic arenavirus vector SIV vaccine reduces setpoint viral load in SIV-challenged rhesus monkeys AV Boopathy, B Sharma, A Nekkalapudi, R Wimmer, M Gamez-Guerrero, ... npj Vaccines 8 (1), 175, 2023 | 4 | 2023 |
| Progress in vaccine development for infectious diseases—a Keystone Symposia report J Cable, BS Graham, RA Koup, RA Seder, K Karikó, N Pardi, DH Barouch, ... Annals of the New York Academy of Sciences 1524 (1), 65-86, 2023 | 4 | 2023 |
| Neutralizing possibilities of whole virion and mRNA vaccine triggered antibodies of Wuhan strain of SARS-CoV-2 with receptor binding domains of spike proteins of Delta and … S Barthwal, B Angel, A Angel, V Joshi, BM Shareef, NM Peer, P Khaneja, ... Asian Pacific Journal of Tropical Medicine 16 (2), 92-94, 2023 | 3 | 2023 |
| Molecular Basis of Host-Virus Interactions to Explain Relative Transmission and Severity Caused by Omicron and Delta variants of SARS-CoV-2 V Joshi, BM Shareef, B Angel, A Angel, R Joshi, AS Khan, P Khaneja, ... J Pure Appl Microbiol 17 (3), 1612-9, 2023 | 1 | 2023 |
| Malignant tumor and host tissue CXCR2 expression promotes mammary tumor growth, angiogenesis, and progression KC Nannuru, B Sharma, ML Varney, RK Singh CLINICAL & EXPERIMENTAL METASTASIS 28 (2), 200-200, 2011 | 1 | 2011 |
| Enhancing efficacy of drugs by targeting CXCR2 receptor signaling for the treatment of malignant breast cancer B Sharma, D Nawandar, ML Varney, KC Nannuru, RK Singh Cancer Research 70 (8_Supplement), 5462-5462, 2010 | 1 | 2010 |
Rakesh K. SinghUniversity of Nebraska Medical CenterVerified email at unmc.edu
